Our results are compatible with studies that reporting reduced MCPH1 DNA copy number in 72% (39/54) of breast cancers [16] and to our own findings of reduced Microcephalin expression in 93/319 (29%) of breast cancer samples, particularly in the higher grade tumours [28]. This evidence concerns the gene MCPH1 and breast cancer.